Deep, focused following-generation sequencing has unveiled that subclonal mutations (i.e., All those existing in just a fraction of tumor cells) may be detected for all driver genes and therefore are connected to speedy disorder development and very poor consequence.11–13 This is particularly relevant for TP53 mutations specified The point that,